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Introduction: Diabetes mellitus (DM) requires continuing health care as prevention of the rise of acute 
complications and lowering the risk of development and further progression of chronic complications. The 
choice of the treatment method is fundamental for reaching the therapeutic aims. That is why medical staff 
members should continuously monitor information about new possibilities of the therapy including the current 
ones which are still continuously specified. 
The management of diabetes mellitus requires the active approach of patient as well as the complex medical 
health care. The emphasis should also be placed on his/her adherence or attitudes and on the motivation to 




Aim: The aim of the search part was to analyze the possibilities of DM type 1 pharmacotherapy with the 
focus on the comparison of the treatment of CSII (continuous subcutaneous insulin infusion) and MDI 
(multiple daily injections) in adult diabetics with DM type 1 and the possibility of use of some peroral 
antidiabetic drugs (PAD) in the adjuvant treatment of patients with DM type 1. 
We also analysed selected drug interactions (DI) in the elderly with DM with the focus on the risk of 
hypoglycaemia in combinative treatment and the combination of antidiabetic drugs with hypolimidaemics and 
antihypertensives. 
Methodology: The literature search in the indexed database PubMed was carried out. The Micromedex® 
database (Drugdex system®), Kompendium Infopharm and the Database of registered pharmaceuticals of 
SÚKL (State Institute for Drug Control) were checked in the case of DI analysis as well. 
Results: CSII leads to slightly lower values of the glycated haemoglobin (HbA1c) and to the need of lower 
insulin doses. If there is a weight change after the changeover to CSII, the weight is gently higher. There is a 
lower frequency of hypoglycaemia in CSII when compared with MDI. There was not enough information in 
most found works for the comparison of the frequency of further side treatment effects. 
There has not been enough evidence in common clinical practice for the use of adjuvant treatment of PAD in 
DM type 1. Metformin, pioglitazone and incretins appear to potentially be the most suitable ones. Antidiabetic 
DI are not very frequent and mostly have a minimal impact in clinical practice. In the elderly one should 
especially consider the possibility of increasing the risk of hypoglycaemia in the combinative treatment. The 
lowest risk of interactions in the elderly with DM is in the cases of insulin, metformin, DPP-4 inhibitors (except 
for saxagliptin), GLP-1 analogs and acarbose treatment. 
Conclusion: The strict enforcement of new therapeutic ways at the expense of the time-proved curative 
methods does not have to be unambiguously beneficial especially from the point of view of the manifold 
higher costs. On the other hand, it is necessary to monitor the information about the effectiveness and safety 
of accessible management strategies and even potentially new usable therapy possibilities for providing the 
optimal health care in patients with DM. The cooperation of other medical staff members and pharmacists 




The analysis of adherence to medical recommendations and identification of specific adherence correlates in 
adults with type 1 diabetes 
Aim: The aim of the work was to analyze the adherence to medical recommendations and identify its 
potential correlates in adults with type 1 diabetes. 
Methodology: An observational cross-sectional study based on questionnaires and data from patients’ 
medical records was carried out in the Diabetes Center of the University Hospital in Hradec Králové. The 
adherence to medical recommendations was evaluated by means of the Self-Care Inventory-Revised and 
the satisfaction with the treatment by the help of the Diabetes Treatment Satisfaction Questionnaire-status 
version. Selected parametric and non-parametric tests were used at the statistical evaluation in PASW 18.0 
software. 
Results: The study included 111 patients (59.5 % women), 53 % of them were treated by CSII. The average 
age was 42.4 years, the average HbA1c 66.2±15.3 mmol/mol and the average insulin doses 0.6±0.3 
IU/kg/day. The number of hypoglycaemia episodes (including the serious ones) in the course of the last 
month was 3.6±3.2 on average. It is especially problematic for patients to keep the regime steps. The 
adherence was associated with the satisfaction with treatment (B = 0.495; P = 0.004) and the frequency of 
glycaemia self-monitoring before meals (B = 0.267; P = 0.003). The adherence was not related to any of the 
demographic or clinical characteristics not even to hypoglycaemia frequency or undesirable incidents during 
the treatment. 
Conclusion: The satisfaction with treatment is the key factor that one should pay attention to within the 
context of the adherence in adults with type 1 diabetes. 
 
The analysis of eating habits with the focus on fat and fiber intake and the relations between the intake of fat 
and fiber in diet and the basic parameters of the illness compensation in patients with type 2 diabetes 
Aim: The aim of this work was to analyze the eating habits with the focus on the fat and fiber intake in diet 
and relations between the fat and fiber intake and basic parameters of the illness compensation in patients 
with type 2 diabetes. 
Methodology: An observational cross-sectional study using the Fat- and Fiber-related Diet Behavior 
Questionnaire was carried out. It was supplemented by questions about gender, age, the length of diabetes, 
and the data from the patients’ medical records. The study was accomplished in 3 diabetes outpatient clinics 
in Hradec Králové and Pardubice. Selected parametric and non-parametric tests were used at the statistical 
evaluation in PASW 18.0 software. 
Results: The study included 200 patients (54.5 % men) of an average age of 66.2±10.1. The average HbA1c 
was 59.0±18.9 mmol/mol. The patients get better results in lowering the fat intake than in increasing the fiber 
intake in diet. The patients rather modify the meals (e.g. to a lower fat amount) that they are used to 
consuming than exclude them from their diet or substitute them by another type of food. Men take in a higher 
fat amount than women in diet (P = 0.002). Women with a higher value of HbA1c and waist circumference 
refer to a lower fat intake in their diet (ρ = -0.248; P = 0.027; ρ = -0.254; P = 0.024 respectively). 
Conclusion: Patients with type 2 diabetes report different dietary behaviour in dependence on gender. The 
submitted results can help increase the effectiveness of dietary education thereby even the adherence of 
patients in the field of dietary recommendations. Medical staff members educating diabetics should 
especially focus on the way how to specifically support the fiber intake in patients. 
